A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
Clinical trial NCT01503502 · UNKNOWN
Trial details
- NCT number
- NCT01503502
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2012-06-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.